[HTML][HTML] Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns

M Assefa - Pneumonia, 2022 - Springer
Bacterial pneumonia is one of the most serious public health issues owing to its medical and
economic costs, which result in increased morbidity and mortality in people of all ages …

[HTML][HTML] Antimicrobial materials for endotracheal tubes: A review on the last two decades of technological progress

D Alves, T Grainha, MO Pereira, SP Lopes - Acta Biomaterialia, 2023 - Elsevier
Ventilator-associated pneumonia (VAP) is an unresolved problem in nosocomial settings,
remaining consistently associated with a lack of treatment, high mortality, and prolonged …

Multidrug-resistant and extensively drug-resistant enterobacteriaceae: prevalence, treatments, and outcomes–a retrospective cohort study

H Alkofide, AM Alhammad, A Alruwaili… - Infection and Drug …, 2020 - Taylor & Francis
Background Drug-resistant gram-negative bacteria (GNB) are a global public health threat,
especially in intensive care units (ICU). This study explored the prevalence of drug-resistant …

[HTML][HTML] Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal-a prospective cohort study

S Siwakoti, A Subedi, A Sharma, R Baral… - … Resistance & Infection …, 2018 - Springer
Background Infections caused by multi-drug resistant gram-negative bacterial infections are
the principle threats to the critically ill patients of intensive care units. Increasing reports of …

Estimates of sepsis prevalence and outcomes in adult patients in the ICU in India: a cross-sectional study

NE Hammond, A Kumar, P Kaur, BKT Vijayaraghavan… - Chest, 2022 - Elsevier
Background Sepsis is a global health problem. Limited data exist on the prevalence of
sepsis using current definitions in ICUs in India. Research Question In adult patients …

Clinical Characteristics and Prognosis of Hospital-Acquired Klebsiella pneumoniae Bacteremic Pneumonia versus Escherichia coli Bacteremic Pneumonia: A …

F Li, J Zhu, Y Hang, Y Chen, S Gu, S Peng… - Infection and Drug …, 2023 - Taylor & Francis
Objective This research aimed to investigate the variations in clinical features and prognosis
of HABP caused by E. coli and K. pneumoniae. We also aimed to evaluate the risk variables …

Studi retrospektif gambaran resistensi bakteri terhadap antibiotik

NK Sukertiasih, F Megawati… - Jurnal Ilmiah …, 2021 - e-journal.unmas.ac.id
Abstract Menurut Center for Disease Control and Prevention resistensi bakteri terhadap
antibiotik masih menjadi masalah kesehatan global. Tingginya angka kejadian resistensi …

[HTML][HTML] Risk Factors and Protective Factors against Ventilator-Associated Pneumonia—A Single-Center Mixed Prospective and Retrospective Cohort Study

J Pawlik, L Tomaszek, H Mazurek… - Journal of Personalized …, 2022 - mdpi.com
Introduction: Understanding the factors associated with the development of ventilator-
associated pneumonia (VAP) in critically ill patients in the intensive care unit (ICU) will allow …

[HTML][HTML] Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated …

J Liu, M Shao, Q Xu, F Liu, X Pan, J Wu, L Xiong… - Annals of Intensive …, 2022 - Springer
Background The mortality of extensively drug-resistant Gram-negative (XDR GN) bacilli-
induced ventilator-associated pneumonia (VAP) is extremely high. The purpose of this study …

[HTML][HTML] Use of polymyxin B with different administration methods in the critically ill patients with ventilation associated pneumonia: a single-center experience

R Shi, Y Fu, Y Gan, D Wu, S Zhou… - Frontiers in …, 2023 - frontiersin.org
Background: Whether nebulized polymyxin B should be used as an adjunctive therapy or
substitution strategy to intravenous polymyxin B for the treatment of ventilator-associated …